Knut Dybwik Selected Research

Sepsis (Septicemia)

1/2017	Combined inhibition of C5 and CD14 efficiently attenuated the inflammatory response in a porcine model of meningococcal sepsis.
11/2015	Combined inhibition of complement and CD14 improved outcome in porcine polymicrobial sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Knut Dybwik Research Topics

Disease

2	Sepsis (Septicemia) 01/2017 - 11/2015
1	Death (Near-Death Experience) 02/2022
1	Air Embolism (Gas Embolism) 01/2022
1	Thromboinflammation 01/2022
1	Hemorrhagic Shock 12/2021
1	Fat Embolism 12/2021
1	COVID-19 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2018
1	Paralysis (Palsy) 01/2016
1	Granuloma 01/2016
1	Pathologic Constriction (Stenosis) 01/2016
1	Inflammation (Inflammations) 11/2015
1	Fever (Fevers) 11/2003

Drug/Important Bio-Agent (IBA)

2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 11/2015
2	Complement System Proteins (Complement)IBA 01/2017 - 11/2015
1	Complement C3 (C3 Complement)IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020

Therapy/Procedure

3	Critical Care (Surgical Intensive Care) 02/2022 - 11/2003
2	Tracheostomy 11/2018 - 01/2016
1	Pericardiectomy 12/2021
1	Sternotomy 12/2021
1	Resuscitation 12/2021
1	Intravenous Infusions 01/2017
1	Anesthesia 11/2015